As soon as Pfizer and its partner BioNTech announced that their Covid-19 vaccine has 95% efficacy, stock markets across the globe went berserk to price in an economic recovery. The damage on rubber glove counters was real, with a free fall in their share prices since last week, before bargain hunters came in to bottom fish yesterday.
IT WAS perhaps the only single piece of news that investors around the world wanted to hear. As soon as Pfizer and its partner BioNTech announced that their Covid-19 vaccine has 95% efficacy, stock markets across the globe went berserk to price in an economic recovery.
The damage on rubber glove counters was real, with a free fall in their share prices since last week, before bargain hunters came in to bottom fish yesterday.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
